Skin Cancer, Non-melanoma

References

Citations

  1. American Cancer Society (2006). Nonmelanoma Skin Cancer. Available online: http://documents.cancer.org/118.00/118.00.pdf.

  2. Halpern AC, Myskowski PL (2005). Malignant cutaneous tumors. In DC Dale, DD Federman, eds., ACP Medicine, section 2, chap. 10. New York: WebMD.

  3. National Cancer Institute (2005). Skin Cancer (PDQ): Treatment. Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/skin/healthprofessional/allpages.

  4. Aasi SZ, Leffell DJ (2005). Cancer of the skin. In VT DeVita Jr. et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., vol. 2, pp. 1717–1744. Philadelphia: Lippincott Williams and Wilkins.

  5. Martinez J-C, Otley CC (2001). The management of melanoma and nonmelanoma skin cancer: A review for the primary care physician. Mayo Clinic Proceedings, 76(12): 1253–1265.

  6. American Cancer Society (2006). Cancer Facts and Figures 2006, pp. 1–56. Atlanta: American Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.

  7. Carucci JA, Leffell DJ (2003). Basal cell carcinoma. In IM Freedberg et al., eds., Fitzpatrick's Dermatology in General Medicine, 6th ed., pp. 747–754. New York: McGraw-Hill.

  8. Grossman D, Leffell DJ (2003). Squamous cell carcinoma. In IM Freedberg et al., eds., Fitzpatrick's Dermatology in General Medicine, 6th ed., pp. 737–747. New York: McGraw-Hill.

  9. Dinehart SM (2000). The treatment of actinic keratoses. Journal of American Academy of Dermatology, 42: S25–S28.

  10. U. S. Food and Drug Administration (2004). Aldara (imiquimod) for superficial basal cell carcinoma. Available online: http://www.fda.gov/bbs/topics/news/2004/NEW01088.html.

  11. Morton CA, et al. (2002). Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. British Journal of Dermatology, 146: 552–567.

Other Works Consulted

  • U.S. Preventive Services Task Force (2003). Counseling to prevent skin cancer: Recommendations and rationale. MMWR, 52(RR15): 13–17.


Go to previous sectionGo to previous sectionGo to top of pageGo to top of pageGo to next sectionGo to next section

Author: Shannon Erstad, MBA/MPH
Carrie Henley
Last Updated: January 29, 2007
Medical Review: Patrice Burgess, MD - Family Medicine
Anne C. Poinier, MD - Internal Medicine
Alexander H. Murray, MD, FRCPC - Dermatology

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Topic Overview
 Health Tools Click here to view Health Tools.
 Cause
 Symptoms
 What Happens
 What Increases Your Risk
 When To Call a Doctor
 Examinations and Tests
 Treatment Overview
 Prevention
 Home Treatment
 Medications
 Surgery
 Other Treatment
 Other Places To Get Help
 Related Information
Arrow PointerReferences
 Credits